Wnt-7a Antibodies

Santa Cruz Biotechnology offers a broad range of Wnt-7a monoclonal antibodies for research focused on understanding the Wnt signaling pathway. Wnt-7a Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Wnt-7a is a crucial member of the Wnt family of proteins, playing a significant role in embryonic development, cell differentiation, and tissue homeostasis. The involvement of Wnt-7a in the regulation of cell signaling pathways makes it essential for understanding various biological processes and diseases, including cancer and developmental disorders. Research focused on Wnt-7a can provide insights into therapeutic targets and potential interventions in these conditions. Scientists worldwide rely on Wnt-7a monoclonal antibodies to advance their understanding of cellular mechanisms and pathways. Investigating Wnt-7a expression patterns helps reveal its role in normal development and disease progression. The high specificity of Santa Cruz Biotechnology monoclonal antibodies enables researchers to make meaningful contributions to scientific knowledge in cell signaling and development.